HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of fcgamma receptor gene polymorphism in pediatric renal transplant rejections.

Abstract
The aim of the study reported herein was to determine whether panel-reactive antibody (PRA) and FcgammaR gene polymorphism act in the same way on acute rejection (AR) and chronic rejection (CR) in children who have undergone renal transplantation. The study evaluated 56 children who underwent transplantation and 115 healthy subjects. AR was observed in 13 cases; CR was observed in 7 patients. The assessment for FcgammaR of the groups in which AR was present showed statistical significance only for the FcgammaIIA genotype. There was no statistical significance for either the FcgammaIIIA or FcgammaIIIB genotypes. Assessment of the FcgammaIIA, IIIA, and IIIB genotypes of the groups in whom CR was present did not show statistical significance. As a result, the prediction of graft survival among transplant recipients is possible using molecular biology. The results of our study showed that individuals of the FcgammaRIIA genotype seemed to have a poorer prognosis similar to some autoimmune diseases. These individuals constitute a risk group for AR. If other studies are conducted with more patients to demonstrate the relationship of other FcgammaRs to rejection, the resultant predictive knowledge about the value of genotypes may lead to improved outcomes following renal transplantation.
AuthorsN Ozkayin, S Mir, B Afig
JournalTransplantation proceedings (Transplant Proc) Vol. 40 Issue 10 Pg. 3367-74 (Dec 2008) ISSN: 0041-1345 [Print] United States
PMID19100392 (Publication Type: Journal Article)
Chemical References
  • DNA Primers
  • FCGR2B protein, human
  • FCGR3A protein, human
  • Fc gamma receptor IIA
  • Receptors, IgG
  • DNA
Topics
  • Child
  • DNA (genetics, isolation & purification)
  • DNA Primers
  • Follow-Up Studies
  • Genotype
  • Graft Rejection (epidemiology, genetics)
  • Humans
  • Kidney Transplantation (adverse effects)
  • Odds Ratio
  • Polymorphism, Genetic
  • Prognosis
  • Receptors, IgG (genetics)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: